Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed)

The summary for the Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed): The purpose of this Funding Opportunity Announcement (FOA) is to provide opportunities for eligible U.S. small business concerns (SBCs), together with academic partners, in the Northeast region of the Institutional Development Award (IDeA)-eligible states, to apply forIDeA Regional Entrepreneurship Development (I-RED) program awards that support the development of educational products to promote biomedical entrepreneurship in the Northeast region of IDeA states. These educational products are expected to address the needs of IDeA state academic institutions in developing and/or strengthening technology transfer programs that stimulate technological innovation by translating scientific discoveries and technologies from research laboratories into commercial products that improve human health and promote economic growth in the Northeast region of IDeA states.

Federal Grant Title:	Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-22-254
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.859
CFDA Descriptions:	Information not provided
Current Application Deadline:	January 6th, 2023
Original Application Deadline:	January 6th, 2023
Posted Date:	September 16th, 2022
Creation Date:	September 16th, 2022
Archive Date:	February 11th, 2023
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	September 16th, 2022

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-22-254.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34); • Maximizing Access to Research Careers (MARC) (T34); • Medical Scientist Training Program (MSTP) (T32); • Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed); • Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial ...; • Tools for Genetic and Genomic Studies in Emerging Model Organisms; • Evolution of Infectious Diseases; • Mbrs Support of Continuous Research Excellence (Score)
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...